Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Flora McErlane.

Newcastle AuthorsTitleYearFull text
Dr Flora McErlane
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK2021
Dr Flora McErlane
Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups2020
Emerita Professor Helen Foster
Dr Flora McErlane
Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents with Juvenile Idiopathic Arthritis2020
Dr Flora McErlane
Emerita Professor Helen Foster
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study2020
Dr Nicola Smith
Dr Flora McErlane
Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience measures (PROMs/PREMs)2020
Dr Josh Bennett
Dr Nicola Smith
Ravi Mistry
Dr Sharmila Jandial
Emerita Professor Helen Foster
et al.
Can quantitative MRI be used in the clinical setting to quantify the impact of intra-articular glucocorticoid injection on synovial disease activity in juvenile idiopathic arthritis?2019
Dr Flora McErlane
Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis2019
Dr Flora McErlane
Emerita Professor Helen Foster
Dr Nicola Smith
Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership2018
Dr Flora McErlane
Emerita Professor Helen Foster
Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS)2018
Dr Flora McErlane
Emerita Professor Helen Foster
Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials2018
Dr Flora McErlane
Emerita Professor Helen Foster
Effectiveness and safety of TNG inhibitors in adults with juvenile idiopathic arthritis2016
Emerita Professor Helen Foster
Dr Flora McErlane
Estimates of Inactive Disease are Strongly Influenced by Outcome Definition in a Prospective Cohort of Patients with Juvenile Idiopathic Arthritis2016
Dr Flora McErlane
Emerita Professor Helen Foster
Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study2016
Dr Flora McErlane
Emerita Professor Helen Foster
Multicentre audit of disease activity assessment in JIA: JIA Topic Specific Group 20142015
Dr Flora McErlane
Emerita Professor Helen Foster
Trends in Paediatric Rheumatology Referral Times and Disease Activity Indices over A Ten-Year Period among Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Prospective Study (CAPS)2014
Dr Flora McErlane
Emerita Professor Helen Foster
Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register2013
Dr Flora McErlane
Emerita Professor Helen Foster
Minimal Disease Activity in a Clinical Cohort of Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Prospective Study2013
Dr Flora McErlane
Emerita Professor Helen Foster
Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis2013
Dr Flora McErlane
Dr John Davidson
Emerita Professor Helen Foster
Does exlusion of the ESR for JADAS affect validity in the clinical setting in assessment of new-onset juvenile inflammatory arthritis?2012
Dr Flora McErlane
Emerita Professor Helen Foster
Validation of JADAS in international league against rheumatism (ILAR) subtypes of juvenile idiopathic arthritis (JIA)2012